Makin Labs' R&D Unit Gets DSIR Recognition

Makin Laboratories Private Limited's in-house Research and Development unit at Pithampur, Madhya Pradesh, has received recognition from the Department of Scientific and Industrial Research, Government of India. This recognition is valid until March 31, 2029.

The company has been operating in the nutraceutical, herbal, Ayurvedic, and cosmeceutical sectors and has been developing its R&D capabilities at Pithampur since 2018.

According to Yash Sharma, managing director of Makin Laboratories, the recognition from DSIR is a significant achievement for the company. It formally acknowledges the investment and commitment made over the last eight years to build research capabilities in Pithampur.

The R&D facility at Pithampur undertakes various activities such as formulation and analytical development, ingredient standardisation, pilot-scale translation, and commercial scale-up. The company has completed pre-clinical research on its patented technology and has registered one human clinical study with the Clinical Trials Registry-India. Two other studies are at the protocol stage.

Makin Laboratories has also published related research in a Springer journal and has secured three Indian patents. The company has 16 patent applications under examination and has initiated national-phase patent filings in over 40 countries.

Established in 2013 and headquartered in Indore, Makin Laboratories has its manufacturing and R&D facilities in Pithampur. The company follows quality and regulatory standards, including WHO-GMP.

The company is also expanding and modernising its Pithampur R&D facility with modern machinery and research infrastructure. The upgrade, targeted for completion by March 2030, is aimed at strengthening formulation development, its research pipeline, and product development for international markets.

This recognition from DSIR is expected to boost the company's research and development capabilities, enabling it to develop innovative products for the global market.

The recognition is a significant milestone for Makin Laboratories, demonstrating its commitment to research and development in the nutraceutical and herbal sectors.

The company's focus on research and development is expected to contribute to the growth of the industry, providing innovative products and solutions to customers worldwide.

In conclusion, the recognition of Makin Laboratories' R&D unit by DSIR is a significant achievement, highlighting the company's commitment to research and development in the nutraceutical and herbal sectors.

This development is expected to have a positive impact on the company's growth and expansion plans, enabling it to develop innovative products and solutions for the global market.